OrthoPediatrics’ (KIDS) Overweight Rating Reiterated at Piper Sandler

Piper Sandler reaffirmed their overweight rating on shares of OrthoPediatrics (NASDAQ:KIDS – Free Report) in a research report sent to investors on Thursday morning,Benzinga reports. Piper Sandler currently has a $45.00 price objective on the stock, up from their prior price objective of $30.00.

Several other analysts have also issued reports on KIDS. Needham & Company LLC restated a “buy” rating and set a $35.00 target price on shares of OrthoPediatrics in a research report on Wednesday, October 28th. Weiss Ratings reiterated a “sell (d-)” rating on shares of OrthoPediatrics in a research report on Tuesday, November 3rd. Truist Financial increased their price target on shares of OrthoPediatrics from $22.00 to $28.00 and gave the stock a “hold” rating in a research report on Wednesday, October 28th. Lake Street Capital lifted their price target on shares of OrthoPediatrics from $34.00 to $38.00 and gave the stock a “buy” rating in a research note on Wednesday, October 28th. Finally, Stifel Nicolaus lifted their price target on shares of OrthoPediatrics from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Wednesday, October 28th. Seven investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, OrthoPediatrics currently has a consensus rating of “Moderate Buy” and a consensus target price of $33.88.

Read Our Latest Stock Analysis on OrthoPediatrics

OrthoPediatrics Trading Down 2.4%

OrthoPediatrics stock opened at $31.73 on Thursday. The business has a 50-day simple moving average of $26.05 and a two-hundred day simple moving average of $20.66. The company has a market cap of $828.34 million, a P/E ratio of -22.19 and a beta of 0.90. OrthoPediatrics has a 52-week low of $14.42 and a 52-week high of $34.53. The company has a quick ratio of 2.00, a current ratio of 4.55 and a debt-to-equity ratio of 0.29.

OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last released its quarterly earnings results on Tuesday, October 27th. The company reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.02). OrthoPediatrics had a negative net margin of 12.83% and a negative return on equity of 8.10%. The business had revenue of $72.66 million for the quarter, compared to analysts’ expectations of $68.50 million. Analysts predict that OrthoPediatrics will post -1.09 EPS for the current year.

Insiders Place Their Bets

In other news, major shareholder Jennifer N. Pritzker sold 302,369 shares of OrthoPediatrics stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $21.01, for a total transaction of $6,352,772.69. Following the transaction, the insider directly owned 6,201,764 shares of the company’s stock, valued at $130,299,061.64. The trade was a 4.65% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Squadron Capital Llc sold 302,369 shares of OrthoPediatrics stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $21.01, for a total value of $6,352,772.69. Following the transaction, the insider directly owned 6,201,764 shares in the company, valued at approximately $130,299,061.64. The trade was a 4.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 2,100,000 shares of company stock worth $46,747,931 over the last quarter. 32.50% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On OrthoPediatrics

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Aquatic Capital Management LLC bought a new stake in OrthoPediatrics during the 3rd quarter worth approximately $25,000. GAMMA Investing LLC lifted its holdings in OrthoPediatrics by 70.3% during the third quarter. GAMMA Investing LLC now owns 1,165 shares of the company’s stock valued at $26,000 after purchasing an additional 481 shares in the last quarter. Legal & General Group Plc bought a new position in shares of OrthoPediatrics in the second quarter worth approximately $34,000. HighMark Wealth Management LLC bought a new position in shares of OrthoPediatrics in the third quarter worth approximately $111,000. Finally, Quantinno Capital Management LP bought a new position in shares of OrthoPediatrics in the first quarter worth approximately $160,000. 69.05% of the stock is owned by hedge funds and other institutional investors.

OrthoPediatrics Company Profile

(Get Free Report)

OrthoPediatrics Corp. develops and markets orthopedic implants and instruments designed specifically for children and adolescents. Its products support surgeons treating a range of pediatric conditions, including fractures, spinal deformities, limb-length differences and other orthopedic disorders. The company’s portfolio includes systems for trauma and deformity correction, scoliosis treatment, limb lengthening and external fixation, as well as specialized surgical instruments. It also provides related education and support for pediatric orthopedic surgeons and care teams.

Further Reading

Analyst Recommendations for OrthoPediatrics (NASDAQ:KIDS)

Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.